TCGX stock news today

TriGemX Bio, TCGX Acquisition Corp. confidentially submit draft registration statement

The two firms said a draft registration statement was submitted on a confidential basis. Such a filing is an early step toward a possible public listing.

TriGemX Bio, TCGX blank-check firm submit S-4 for merger

A registration statement on Form S-4 has been submitted by TriGemX Bio and TCGX Acquisition covering their planned combination. The tie-up is slated to finish in the first quarter of 2027, when the resulting business expects to list on Nasdaq as 'TGEM'.

Zai Lab secures $250 million in private placement led by TCGX

Zai Lab will receive $250 million through a private placement of equity. TCGX is heading the transaction.

TriGemX Bio to go public via merger with TCGX Acquisition, listing on Nasdaq as TGEM

TriGemX Bio will become a public company by merging with TCGX Acquisition and plans to list on Nasdaq under the ticker TGEM. The combined company is expected to receive about $246 million in gross proceeds when the deal closes.

What is the latest news on TCGX?

Nov 2, 2026: TriGemX Bio, TCGX Acquisition Corp. confidentially submit draft registration statement (Fiscal.ai) · Nov 2, 2026: TriGemX Bio, TCGX blank-check firm submit S-4 for merger (Benzinga) · Oct 24, 2026: Zai Lab secures $250 million in private placement led by TCGX (Fiscal.ai)